NICE recommends DERM for early use within the NHS, while further evidence is gathered – Commentary from Neil Daly, Founder and CEO, Skin Analytics

May 1, 2025

On May 1st 2025, the National Institute for Health and Care Excellence (NICE)…

DERM makes medical history as world’s first autonomous skin cancer detection system is approved for clinical decisions in Europe

February 6, 2025

The Class III CE marking under the European Medical Device Regulation (MDR)…

Skin Analytics achieves Class IIa UKCA Mark for DERM. The UK’s first and only Class IIa certified AI dermatology device

April 19, 2022

Now a Class IIa medical device, DERM, uses machine learning algorithms to…

Deploying Safe and Effective AI in Skin Cancer Pathways

January 27, 2021

In this blog as Medical Director of Skin Analytics, I wanted to share with the…

Skin Analytics response to NHS AI Code of Conduct

March 3, 2020

We believe that all responsible AI companies providing services to the…

Skin Analytics Awarded ISO 13485 Certification

March 3, 2020

ISO 13485:2016 is an internationally recognised quality standard for medical…

AI Standards for Healthcare

May 8, 2017

The last thing we want to see is innovation being suppressed under volumes of…